ADM Tronics Unlimited Inc.
Northvale, NJ - ADM Tronics Unlimited, Inc. (OTCQB - ADMT) announced today that in accordance with its previously distributed shareholder's letter of October 26, 2016 the company will make a concerted effort to ensure that its shareholders, the investing public and the medical device technology industry will be kept abreast of all current events regarding the Company's progress.
Andre' DiMino, CEO of ADMT stated "Although we can not make any promises, we have reason to believe that the Company is on the threshold of achieving its 12th and 13th consecutive quarters of increased revenues and profits. Fortunately, we are seeing an increase in requests and order flow since November 8, 2016, when a more med tech friendly administration was elected." In addition, the Company will be launching its newly designed website, which will be reflective of ADMT's burgeoning position within the industry and to make real time information available to anyone with an interest in the Company. "Our new website will illustrate our cutting-edge, state-of-the-art facility and expanding capabilities," continued DiMino.
Matthew Drummer, Chief Science Officer of ADMT, commented "Over and above Andre's enthusiastic prognosis of the fundamental outlook for the company, management believes our proprietary Medical Device technologies, such as the Alvio Spirometry device, the Sonotron technology and the Aurex-3 tinnitus treatment technology, can propel the Company to play a more recognizable role within the industry."
Mr DiMino added "Based on the palpable potential inherent within our Company today, and our expanded capability to deliver more superior products, we believe that 2017 will be a very promising year for ADM Tronics."
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Medical Device Design, Engineering, Regulatory and Manufacturing Services; Proprietary Electronic Medical Devices; and Eco-Friendly, Water-Based Formulations. ADMT’s multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D prototyping, precision instrumentation and specialized software and peripherals, for the research, development and commercialization of diversified technologies. Additional information is available at the Company’s websites - admtronics.com and concepttoquantity.com.
Except for historical information contained herein, the matters set forth in this news release are “forward looking” statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT’s filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.
Contact: Andre’ DiMino 201-767-6040, email@example.com